Metraipolis › archive › dc_5d3a43fc85ba
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors — Europe PMC PMID:41696493
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41696493
- DOI
- 10.1093/noajnl/vdaf250
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T19:30:53.083Z
- SHA-256 of the archived text
5f475493f9bcc8985066dc05c32af161f481c9fed3141780e944bed18a023bfc- Stable URL of this page
https://metraipolis.com/documento/dc_5d3a43fc85ba
How to cite
Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors — Europe PMC PMID:41696493 — Europe PMC (en), https://europepmc.org/article/MED/41696493 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5d3a43fc85ba (Metraipolis archive dc_5d3a43fc85ba, sha256 5f475493f9bcc8985066dc05c32af161f481c9fed3141780e944bed18a023bfc)
BibTeX
@misc{dc5d3a43fc85ba,
title = {Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors — Europe PMC PMID:41696493},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41696493},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5d3a43fc85ba; sha256 5f475493f9bcc8985066dc05c32af161f481c9fed3141780e944bed18a023bfc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41696493. Agents can read the archived copy with the MCP tool read_document.